A device that automatically measures DNA damage
An automated device for quantifying DNA damage
This study is working on a new device that makes it easier and faster to measure DNA damage, which can help us learn more about diseases like cancer and brain disorders, ultimately aiming to improve how we monitor and treat these conditions for patients.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Engineering Resources Group, INC. NIH-funded |
| Lab location | 1 site (Pembroke Pines, United States) |
| Project ID | NIH-10924884 on NIH RePORTER |
What this research studies
This research focuses on developing an automated device that quantifies DNA damage, which is crucial for understanding various diseases like cancer and neurodegeneration. The project aims to enhance the comet assay, a common method for measuring DNA damage, by automating the process to reduce time and errors associated with manual handling. By streamlining this assay, the research seeks to make DNA damage assessment more routine and accessible, potentially improving disease understanding and treatment. Patients may benefit from advancements in disease monitoring and treatment strategies derived from improved DNA damage assessments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals over 21 years old who may be affected by diseases associated with DNA damage, such as cancer or neurodegenerative disorders.
Not a fit: Patients who do not have conditions related to DNA damage or are under 21 years old may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and efficient assessments of DNA damage, improving disease diagnosis and treatment options for patients.
How similar studies have performed: Other research has successfully utilized automation in laboratory assays, indicating a promising potential for this approach in DNA damage quantification.
Where this research is happening
Pembroke Pines, United States
- Engineering Resources Group, INC. — Pembroke Pines, United States (Active)
Researchers
- Principal investigator: Ross, Christopher — Engineering Resources Group, INC.
- Study coordinator: Ross, Christopher
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.